[Interferon therapy for chronic hepatitis B].
Kakumu
Shinichi
S
Division of GI, Department of Medicine, Aichi Medical University School of Medicine.
D000998:Antiviral Agents / Q000008:administration & dosage*; D015415:Biomarkers / Q000097:blood; D002986:Clinical Trials as Topic; D004279:DNA, Viral / Q000097:blood; D004359:Drug Therapy, Combination; D006510:Hepatitis B Antibodies / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood / Q000276:immunology; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D011379:Prognosis; D012254:Ribavirin / Q000008:administration & dosage
D000998:Antiviral Agents; D015415:Biomarkers; D004279:DNA, Viral; D006510:Hepatitis B Antibodies; D006513:Hepatitis B e Antigens; D016898:Interferon-alpha; D012254:Ribavirin